Timosaponin composition and application thereof in viral myocarditis treatment
The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. Accord...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. According to the invention, the proliferation of myocardial tissue viruses can be inhibited obviously; the myocardial cells and tissues can be protected well; and the treatment efficiency of viral myocarditis is improved.
本发明公开了一种知母皂苷组合物,所述组合物含有知母皂苷AⅢ、知母皂苷BⅡ和知母皂苷N,其中知母皂苷AⅢ的重量百分含量为22%~34%,知母皂苷BⅡ的重量百分含量为18%~30%,知母皂苷N的重量百分含量为10%~17%,本发明组合物能够明显抑制心肌组织病毒增值,发挥对心肌细胞及组织的保护作用,提高病毒性心肌炎的治疗有效率。 |
---|